In this study, we analyze the proportions of IL-8 in CD4+ and CD8+ naïve T cells in patients with different types of thymic tumors and healthy controls in a discovery set, and validate them in an independent set with 186 cases, to evaluate the utility of IL-8 in the diagnosis and surveillance of thymoma. The gene discussed is CD4; the disease is thymus neoplasm.